Skip to content
Search

Latest Stories

Ten million doses from India won't impact poor nations' vaccine access, says UK minister

Ten million doses from India won't impact poor nations' vaccine access, says UK minister

UK vaccine deployment minister Nadhim Zahawi has defended a shipment of ten million doses of Covishield en route from India amid some concerns that it would impact supplies of COVID-19 vaccines for poorer nations.

The minister in charge of overseeing the UK's vaccination programme said the vaccine doses developed by the Serum Institute of India, in collaboration with Oxford/AstraZeneca, were always intended for Britain and that assurances have been sought that the delivery would not impact other supplies.


“We, of course, sought assurances from AstraZeneca and from Serum that our doses will not impact their commitment to the low-income and middle-income countries of the world,” Zahawi told the Associated Press in an interview on Friday.

“And they are making about 300 million doses available to low- and middle-income countries. You’ve seen those arrive in Accra in Ghana, last week and the Philippines this week… and Ivory Coast as well. And you’re going to see much more of that volume also going out,” he said.

Non-governmental organisations such as Medecins Sans Frontieres (MSF) had raised concerns that shipments from India would reduce supplies to developing countries.

The minister insisted this was not the case and that supplies around the world would also be deployed through the United Nations backed COVAX system.

Britain has acquired the rights to around 457 million doses of various vaccines, estimated at three times the total needed to fully vaccinate everyone in the country.

While some of the leftover doses may be offered through bilateral relationships, “the bulk of it will be offered through COVAX,” Zahawi said.

Meanwhile, in an update from Downing Street on Friday, UK health secretary Matt Hancock announced that as of midnight on Thursday, 21.3 million people have been vaccinated in the UK – which is two fifths of the entire adult population of the country.

The government has set a July-end target to vaccinate all adults with at least one of two-dose vaccines.

“We’re on course to hit our target of offering a first dose to everyone who’s 50 or over, or part of an at-risk group, by April 15. And all adults by the end of July," said Hancock.

The minister also confirmed that coronavirus cases in the UK were “falling steadily” and that the country was headed in the “right direction” with the pandemic.

The average daily number of cases is now 6,685 – the lowest since late September 2020 and the weekly case rate across the UK is now 84 per 100,000.

"The vaccine roll-out has allowed us to set out our roadmap for how we’ll carefully lift some of the restrictions that we've all endured for far too long,” added Hancock.

It comes as the UK begins its first phase of lifting strict lockdown restrictions with the reopening of schools from Monday.

The coronavirus has so far killed 124,495 people, along with over 4.2 million confirmed cases, in the UK.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less